TSS
RPTX

Two Sigma Securities’s Repare Therapeutics RPTX Stock Holding History

Two Sigma Securities’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,987
Closed -$18.7K – 1991
2025
Q1 		$18.7K Buy
+18,987
New +$22.9K ﹤0.01% 1112

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's RPTX Position: Q2 2025 in Review

Two Sigma Securities sold out of Repare Therapeutics (RPTX) in Q2 2025, closing a stake of 18,987 shares — an estimated $18.7K sold.

Two Sigma Securities first reported a position in RPTX in Q1 2025 and held it in 1 quarter. The position peaked at $18.7K in Q1 2025. 50 funds tracked by Wall St. Rank hold RPTX as of Q2 2025.

  • Two Sigma Securities reported no remaining Repare Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 18,987 Repare Therapeutics shares in Q2 2025, an estimated $18.7K.
  • Two Sigma Securities first reported a position in Repare Therapeutics in Q1 2025 and held it in 1 quarter.
  • Two Sigma Securities's Repare Therapeutics position peaked at $18.7K in Q1 2025.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.